
Acasti Pharma ACST
Quarterly report 2025-Q4
added 02-12-2026
Acasti Pharma P/B Ratio 2011-2026 | ACST
Annual P/B Ratio Acasti Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.612 | 0.52 | 0.361 | 0.187 | 0.266 | 4.26 | 4.52 | 2.11 | 831 | 0.801 | 1.92 | 3.24 | 16.3 | 9.7 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 831 | 0.187 | 62.6 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
1.66 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.115 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.58 | $ 16.88 | -2.43 % | $ 789 M | ||
|
AgeX Therapeutics
AGE
|
7.09 | - | -10.17 % | $ 12.2 K | ||
|
Compugen Ltd.
CGEN
|
2.26 | $ 2.79 | -8.09 % | $ 261 M | ||
|
Coherus BioSciences
CHRS
|
3.71 | $ 1.6 | -2.15 % | $ 187 M | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
2.82 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
1.01 | $ 7.56 | -3.45 % | $ 207 M | ||
|
Athira Pharma
ATHA
|
0.036 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
7.43 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
-0.0532 | - | -32.59 % | $ 7.61 M | ||
|
Esperion Therapeutics
ESPR
|
-1.86 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Exelixis
EXEL
|
5.42 | $ 50.41 | -1.36 % | $ 13.7 B | ||
|
Fortress Biotech
FBIO
|
1.25 | $ 2.43 | 5.65 % | $ 67.8 M | ||
|
Midatech Pharma plc
MTP
|
173 | - | -18.52 % | $ 27.3 M | ||
|
Forte Biosciences
FBRX
|
5.5 | $ 23.1 | -3.57 % | $ 299 M | ||
|
Fennec Pharmaceuticals
FENC
|
4.76 | $ 9.76 | 5.63 % | $ 279 M | ||
|
AbCellera Biologics
ABCL
|
0.995 | $ 4.09 | -7.05 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.59 | - | $ 423 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
BioNTech SE
BNTX
|
1.15 | $ 89.16 | -3.08 % | $ 21.5 B | ||
|
Checkmate Pharmaceuticals
CMPI
|
0.759 | - | - | $ 231 M | ||
|
Galectin Therapeutics
GALT
|
-1.41 | $ 2.22 | -5.74 % | $ 142 M | ||
|
Gilead Sciences
GILD
|
3.11 | $ 130.07 | -1.51 % | $ 162 B | ||
|
Genmab A/S
GMAB
|
0.052 | $ 26.8 | -0.37 % | $ 1.73 B | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
0.505 | $ 3.41 | -2.25 % | $ 5.61 M | ||
|
Aeterna Zentaris
AEZS
|
1.12 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
Grifols, S.A.
GRFS
|
0.525 | $ 7.74 | -0.64 % | $ 5.26 B | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
0.0227 | $ 0.72 | -1.05 % | $ 32.9 M | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
Eton Pharmaceuticals
ETON
|
21.4 | $ 29.69 | -0.92 % | $ 799 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 21.51 | -0.3 % | $ 2.74 B | ||
|
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M |